{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T21:38:31Z","timestamp":1769031511823,"version":"3.49.0"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>\n                    Portugal has one of the highest incidence rates of tuberculosis (TB) in Western Europe and, historically, multidrug-resistant (MDR) cases have been strongly associated with\n                    <jats:italic>Mycobacterium tuberculosis<\/jats:italic>\n                    strains pertaining to the endemic Q1 and Lisboa3 clades. Notwithstanding, the contribution of drug resistance-associated allelic configurations in these clades to differing levels of drug resistance and their relationship with drug efficacy has yet to be uncovered. A representative sample of the drug-resistant\n                    <jats:italic>M. tuberculosis<\/jats:italic>\n                    population in Portugal, comprised of 40 clinical strains were subjected to whole genome sequencing for characterization of allelic combinations of drug resistance-associated mutations and their minimum inhibitory concentrations for 12 anti-TB drugs was determined. Pharmacokinetic (PK) models were generated to ascertain the maximum concentration to which each drug remains efficacious. Drug resistance levels were determined and compared between different allelic configurations. Double\n                    <jats:italic>inhA<\/jats:italic>\n                    and\n                    <jats:italic>embA\/B<\/jats:italic>\n                    mutation genotypes contributed with increased isoniazid and ethambutol resistance levels compared with single mutation configurations, respectively. Significant differences in drug resistance levels were observed between phylogenetic groups for rifamycin, streptomycin and ethionamide, largely explained by the presence\/absence of unique high-level resistance-associated genotypes. The PK models for isoniazid and moxifloxacin suggest an increase in dosage to be ineffective against strains harboring high-level resistance-conferring double\n                    <jats:italic>inhA<\/jats:italic>\n                    mutations and\n                    <jats:italic>gyrA\/B<\/jats:italic>\n                    mutations. Cycloserine and para-aminosalicylic acid are the only drugs predicted to remain efficacious against the majority of tested strains, while the effectiveness of newer drugs like bedaquiline, pretomanid and delamanid have yet to be uncovered. Proper diagnosis of drug resistance-associated mutations provides invaluable insights into the treatment of TB, as different allelic configurations lead to differing drug resistance levels, often rendering drugs ineffective.\n                  <\/jats:p>","DOI":"10.3389\/fmicb.2025.1716549","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T06:41:44Z","timestamp":1768977704000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The microevolutionary trajectory of endemic multidrug-resistant tuberculosis strains in Portugal toward increased drug resistance levels and its clinical significance"],"prefix":"10.3389","volume":"16","author":[{"given":"Pedro","family":"Gomes","sequence":"first","affiliation":[{"name":"Faculdade de Farm\u00e1cia, Research Institute for Medicines, Universidade de Lisboa","place":["Lisbon, Portugal"]}]},{"given":"Paulo","family":"Paix\u00e3o","sequence":"additional","affiliation":[{"name":"Faculdade de Farm\u00e1cia, Research Institute for Medicines, Universidade de Lisboa","place":["Lisbon, Portugal"]}]},{"given":"Fernando","family":"Maltez","sequence":"additional","affiliation":[{"name":"Servi\u00e7o de Doen\u00e7as Infecciosas, Hospital Curry Cabral, Centro Hospitalar Universit\u00e1rio de Lisboa Central","place":["Lisbon, Portugal"]}]},{"given":"Laura","family":"Brum","sequence":"additional","affiliation":[{"name":"SYNLAB Portugal","place":["Lisbon, Portugal"]}]},{"given":"Jody E.","family":"Phelan","sequence":"additional","affiliation":[{"name":"London School of Hygiene and Tropical Medicine","place":["London, United Kingdom"]}]},{"given":"Susana","family":"Campino","sequence":"additional","affiliation":[{"name":"London School of Hygiene and Tropical Medicine","place":["London, United Kingdom"]}]},{"given":"Taane G.","family":"Clark","sequence":"additional","affiliation":[{"name":"London School of Hygiene and Tropical Medicine","place":["London, United Kingdom"]}]},{"given":"Miguel","family":"Viveiros","sequence":"additional","affiliation":[{"name":"Global Health and Tropical Medicine, GHTM, LA-REAL, Instituto de Higiene e Medicina Tropical, IHMT, Universidade NOVA de Lisboa","place":["Lisbon, Portugal"]}]},{"given":"Isabel","family":"Portugal","sequence":"additional","affiliation":[{"name":"Faculdade de Farm\u00e1cia, Research Institute for Medicines, Universidade de Lisboa","place":["Lisbon, Portugal"]}]},{"given":"Jo\u00e3o","family":"Perdig\u00e3o","sequence":"additional","affiliation":[{"name":"Faculdade de Farm\u00e1cia, Research Institute for Medicines, Universidade de Lisboa","place":["Lisbon, Portugal"]}]}],"member":"1965","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"4261","DOI":"10.1128\/AAC.01123-07","article-title":"In vivo validation of the mutant selection window hypothesis with moxifloxacin in a murine model of tuberculosis","volume":"51","author":"Almeida","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1080\/10635150600755453","article-title":"Approximate likelihood-ratio test for branches: a fast, accurate, and powerful alternative","volume":"55","author":"Anisimova","year":"2006","journal-title":"Syst. Biol."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.diagmicrobio.2016.01.019","article-title":"Rifabutin and rifampin resistance levels and associated rpoB mutations in clinical isolates of Mycobacterium tuberculosis complex","volume":"85","author":"Berrada","year":"2016","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","article-title":"Trimmomatic: a flexible trimmer for Illumina sequence data","volume":"30","author":"Bolger","year":"2014","journal-title":"Bioinformatics"},{"key":"ref5","first-page":"585","article-title":"Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons--Florida and New York, 1988-1991","volume":"40","year":"1991","journal-title":"MMWR Morb. Mortal Wkly. Rep."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"e01381","DOI":"10.1128\/AAC.01381-20","article-title":"Population pharmacokinetics of Cycloserine and pharmacokinetic\/Pharmacodynamic target attainment in multidrug-resistant tuberculosis patients dosed with Terizidone","volume":"64","author":"Chirehwa","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"e1001880","DOI":"10.1371\/journal.pmed.1001880","article-title":"Evolution of extensively drug-resistant tuberculosis over four decades: whole genome sequencing and dating analysis of Mycobacterium tuberculosis isolates from KwaZulu-Natal","volume":"12","author":"Cohen","year":"2015","journal-title":"PLoS Med."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/31159","article-title":"Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence","volume":"393","author":"Cole","year":"1998","journal-title":"Nature"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41588-017-0029-0","article-title":"Genome-wide analysis of multi- and extensively drug-resistant Mycobacterium tuberculosis","volume":"50","author":"Coll","year":"2018","journal-title":"Nat. Genet."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.meegid.2018.12.030","article-title":"Macro-geographical specificities of the prevailing tuberculosis epidemic as seen through SITVIT2, an updated version of the Mycobacterium tuberculosis genotyping database","volume":"72","author":"Couvin","year":"2019","journal-title":"Infect. Genet. Evol."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"6837","DOI":"10.1128\/AAC.03285-14","article-title":"Mutations in the embC-embA intergenic region contribute to Mycobacterium tuberculosis resistance to ethambutol","volume":"58","author":"Cui","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref12","first-page":"27","article-title":"Treatment","volume-title":"Drug-resistant tuberculosis: A survival guide for clinicians, third edition\/ 2022 updates","author":"Daley","year":"2022"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"6242","DOI":"10.1128\/AAC.03073-14","article-title":"Pharmacokinetics of Para-aminosalicylic acid in HIV-uninfected and HIV-coinfected tuberculosis patients receiving antiretroviral therapy, managed for multidrug-resistant and extensively drug-resistant tuberculosis","volume":"58","author":"de Kock","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1002\/humu.22981","article-title":"HGVS recommendations for the description of sequence variants: 2016 update","volume":"37","author":"den Dunnen","year":"2016","journal-title":"Hum. Mutat."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"S308","DOI":"10.1093\/cid\/ciy624","article-title":"D-cycloserine pharmacokinetics\/pharmacodynamics, susceptibility, and dosing implications in multidrug-resistant tuberculosis: a Faustian deal","volume":"67","author":"Deshpande","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"102137","DOI":"10.1016\/j.tube.2021.102137","article-title":"Whole-genome sequencing as a tool for studying the microevolution of drug-resistant serial Mycobacterium tuberculosis isolates","volume":"131","author":"do Carmo Guimar\u00e3es","year":"2021","journal-title":"Tuberculosis (Edinb.)"},{"key":"ref17","year":"2025"},{"key":"ref53","volume-title":"Tuberculosis surveillance and monitoring in Europe 2023\u20132021 data","year":"2023"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"19431","DOI":"10.1038\/s41598-021-98862-4","article-title":"Genetic diversity of candidate loci linked to Mycobacterium tuberculosis resistance to bedaquiline, delamanid and pretomanid","volume":"11","author":"G\u00f3mez-Gonz\u00e1lez","year":"2021","journal-title":"Sci. Rep."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2164-11-670","article-title":"The non-clonality of drug resistance in Beijing-genotype isolates of Mycobacterium tuberculosis from the Western cape of South Africa","volume":"11","author":"Ioerger","year":"2010","journal-title":"BMC Genomics"},{"key":"ref20","author":"Li","year":"2013"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","article-title":"The sequence alignment\/map format and SAMtools","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/antibiotics7010018","article-title":"Efflux activity differentially modulates the levels of isoniazid and rifampicin resistance among multidrug resistant and monoresistant Mycobacterium tuberculosis strains","volume":"7","author":"Machado","year":"2018","journal-title":"Antibiotics"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1093\/jac\/dkt090","article-title":"High-level resistance to isoniazid and ethionamide in multidrug-resistant Mycobacterium tuberculosis of the Lisboa family is associated with inhA double mutations","volume":"68","author":"Machado","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1101\/gr.107524.110","article-title":"The genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data","volume":"20","author":"McKenna","year":"2010","journal-title":"Genome Res."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1093\/jac\/dkv345","article-title":"Evidence for the critical role of a secondary site rpoB mutation in the compensatory evolution and successful transmission of an MDR tuberculosis outbreak strain","volume":"71","author":"Meftahi","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"e82551","DOI":"10.1371\/journal.pone.0082551","article-title":"Whole genome sequencing reveals complex evolution patterns of multidrug-resistant Mycobacterium tuberculosis Beijing strains in patients","volume":"8","author":"Merker","year":"2013","journal-title":"PLoS One"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1093\/jac\/dkx427","article-title":"MIC-based dose adjustment: facts and fables","volume":"73","author":"Mouton","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1128\/CMR.8.4.496","article-title":"Antimicrobial agent resistance in mycobacteria: molecular genetic insights","volume":"8","author":"Musser","year":"1995","journal-title":"Clin. Microbiol. Rev."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1093\/cid\/ciw376","article-title":"Official American Thoracic Society\/Centers for Disease Control and Prevention\/Infectious Diseases Society of America clinical practice guidelines: treatment of drug-susceptible tuberculosis","volume":"63","author":"Nahid","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s13073-020-00817-3","article-title":"Robust barcoding and identification of Mycobacterium tuberculosis lineages for epidemiological and clinical studies","volume":"12","author":"Napier","year":"2020","journal-title":"Genome Med."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1093\/molbev\/msu300","article-title":"IQ-TREE: a fast and effective stochastic algorithm for estimating maximum-likelihood phylogenies","volume":"32","author":"Nguyen","year":"2015","journal-title":"Mol. Biol. Evol."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"e7407","DOI":"10.1371\/journal.pone.0007407","article-title":"Genomic diversity among drug sensitive and multidrug resistant isolates of Mycobacterium tuberculosis with identical DNA fingerprints","volume":"4","author":"Niemann","year":"2009","journal-title":"PLoS One"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1038\/s41598-020-59558-3","article-title":"Using genomics to understand the origin and dispersion of multidrug and extensively drug resistant tuberculosis in Portugal","volume":"10","author":"Perdig\u00e3o","year":"2020","journal-title":"Sci. Rep."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"O278","DOI":"10.1111\/1469-0691.12392","article-title":"gidB mutation as a phylogenetic marker for Q1 cluster Mycobacterium tuberculosis isolates and intermediate-level streptomycin resistance determinant in Lisbon, Portugal","volume":"20","author":"Perdig\u00e3o","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1093\/jac\/dkp452","article-title":"Genetic analysis of extensively drug-resistant Mycobacterium tuberculosis strains in Lisbon, Portugal","volume":"65","author":"Perdig\u00e3o","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.ijantimicag.2008.09.021","article-title":"Genetic characterisation of the ethambutol resistance-determining region in Mycobacterium tuberculosis: prevalence and significance of embB306 mutations","volume":"33","author":"Perdig\u00e3o","year":"2009","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/jac\/dks371","article-title":"From multidrug-resistant to extensively drug-resistant tuberculosis in Lisbon, Portugal: the stepwise mode of resistance acquisition","volume":"68","author":"Perdig\u00e3o","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.ijantimicag.2016.07.026","article-title":"Beyond extensively drug-resistant tuberculosis in Lisbon, Portugal: a case of linezolid resistance acquisition presenting as an iliopsoas abscess","volume":"48","author":"Perdig\u00e3o","year":"2016","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1186\/1471-2164-15-991","article-title":"Unraveling Mycobacterium tuberculosis genomic diversity and evolution in Lisbon, Portugal, a highly drug resistant setting","volume":"15","author":"Perdig\u00e3o","year":"2014","journal-title":"BMC Genomics"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1080\/22221751.2020.1774425","article-title":"Emergence of multidrug-resistant Mycobacterium tuberculosis of the Beijing lineage in Portugal and Guinea-Bissau: a snapshot of moving clones by whole-genome sequencing","volume":"9","author":"Perdig\u00e3o","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13073-019-0650-x","article-title":"Integrating informatics tools and portable sequencing technology for rapid detection of resistance to anti-tuberculous drugs","volume":"11","author":"Phelan","year":"2019","journal-title":"Genome Med."},{"key":"ref42","first-page":"207","article-title":"Outbreak of multiple drug-resistant tuberculosis in Lisbon: detection by restriction fragment length polymorphism analysis","volume":"3","author":"Portugal","year":"1999","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1093\/bioinformatics\/btq706","article-title":"Phangorn: phylogenetic analysis in R","volume":"27","author":"Schliep","year":"2011","journal-title":"Bioinformatics"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1128\/JCM.02501-08","article-title":"Quantitative drug susceptibility testing of Mycobacterium tuberculosis by use of MGIT 960 and EpiCenter instrumentation","volume":"47","author":"Springer","year":"2009","journal-title":"J. Clin. Microbiol."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"e3001755","DOI":"10.1371\/journal.pbio.3001755","article-title":"Genome-wide association studies of global Mycobacterium tuberculosis resistance to 13 antimicrobials in 10,228 genomes identify new resistance mechanisms","volume":"20","year":"2022","journal-title":"PLoS Biol."},{"key":"ref46","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1385\/1-59259-147-7:165","article-title":"Restriction fragment length polymorphism typing of mycobacteria","volume-title":"Mycobacterium tuberculosis","author":"van Soolingen","year":"2001"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"e0116421","DOI":"10.1128\/AAC.01164-21","article-title":"Role of epistasis in amikacin, kanamycin, Bedaquiline, and Clofazimine resistance in Mycobacterium tuberculosis complex","volume":"65","author":"Vargas","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1128\/AAC.46.9.2804-2810.2002","article-title":"Isoniazid-induced transient high-level resistance in Mycobacterium tuberculosis","volume":"46","author":"Viveiros","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref49","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S1473-3099(12)70277-3","article-title":"Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: a retrospective observational study","volume":"13","author":"Walker","year":"2013","journal-title":"Lancet Infect. Dis."},{"key":"ref50","volume-title":"Meeting report of the WHO expert consultation on the definition of extensively drug-resistant tuberculosis","year":"2021"},{"key":"ref51","volume-title":"Catalogue of mutations in","year":"2023"},{"key":"ref52","volume-title":"Global tuberculosis report 2024","year":"2024"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13073-016-0270-7","article-title":"SpoTyping: fast and accurate in silico Mycobacterium spoligotyping from sequence reads","volume":"8","author":"Xia","year":"2016","journal-title":"Genome Med."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2025.1716549\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T06:41:46Z","timestamp":1768977706000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2025.1716549\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":54,"alternative-id":["10.3389\/fmicb.2025.1716549"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2025.1716549","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,21]]},"article-number":"1716549"}}